ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Type 2 Diabetes Medication Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-26G5731
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Type 2 Diabetes Medication Market Insights Forecast to 2028
BUY CHAPTERS

Global Type 2 Diabetes Medication Market Research Report 2025

Code: QYRE-Auto-26G5731
Report
July 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Novartis
Novo Nordisk
Johnson & Johnson
Boehringer Ingelheim
Bristol–Myers Squibb
Eli Lilly
Merck
Sanofi
Pfizer Inc
Astellas Pharma
Daiichi Sankyo
Biocon Ltd.
Glenmark
Bayer
Takeda
Sun Pharma

Type 2 Diabetes Medication Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Type 2 Diabetes Medication Market

Type 2 Diabetes Medication Market

The global market for Type 2 Diabetes Medication was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
This Report focus on medications for type 2 diabetes.
People with type 2 diabetes are often given medications including insulin to help manage their blood glucose levels. Most of these medications are in the form of tablets, but some are given by injection. Tablets or injections are intended to be used in conjunction with healthy eating and regular physical activity, not as a substitute.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Type 2 Diabetes Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 2 Diabetes Medication.
The Type 2 Diabetes Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Type 2 Diabetes Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Type 2 Diabetes Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Type 2 Diabetes Medication Market Report

Report Metric Details
Report Name Type 2 Diabetes Medication Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZeneca, Novartis, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck, Sanofi, Pfizer, Astellas Pharma, Daiichi Sankyo, Biocon, Glenmark, Bayer AG, Takeda, Sun pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Type 2 Diabetes Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Type 2 Diabetes Medication Market report?

Ans: The main players in the Type 2 Diabetes Medication Market are AstraZeneca, Novartis, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck, Sanofi, Pfizer, Astellas Pharma, Daiichi Sankyo, Biocon, Glenmark, Bayer AG, Takeda, Sun pharma

What are the Application segmentation covered in the Type 2 Diabetes Medication Market report?

Ans: The Applications covered in the Type 2 Diabetes Medication Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Type 2 Diabetes Medication Market report?

Ans: The Types covered in the Type 2 Diabetes Medication Market report are Biguanides, Sulphonylureas, Thiazolidinediones, Alpha-glucosidase Inhibitors, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT-2 Inhibitors, Insulins

Recommended Reports

Antidiabetic Medications

Related Chronic Diseases

Prescription Pharmaceuticals

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type 2 Diabetes Medication Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biguanides
1.2.3 Sulphonylureas
1.2.4 Thiazolidinediones
1.2.5 Alpha-glucosidase Inhibitors
1.2.6 DPP-4 Inhibitors
1.2.7 GLP-1 Receptor Agonists
1.2.8 SGLT-2 Inhibitors
1.2.9 Insulins
1.3 Market by Application
1.3.1 Global Type 2 Diabetes Medication Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Type 2 Diabetes Medication Market Perspective (2020-2031)
2.2 Global Type 2 Diabetes Medication Growth Trends by Region
2.2.1 Global Type 2 Diabetes Medication Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Type 2 Diabetes Medication Historic Market Size by Region (2020-2025)
2.2.3 Type 2 Diabetes Medication Forecasted Market Size by Region (2026-2031)
2.3 Type 2 Diabetes Medication Market Dynamics
2.3.1 Type 2 Diabetes Medication Industry Trends
2.3.2 Type 2 Diabetes Medication Market Drivers
2.3.3 Type 2 Diabetes Medication Market Challenges
2.3.4 Type 2 Diabetes Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Type 2 Diabetes Medication Players by Revenue
3.1.1 Global Top Type 2 Diabetes Medication Players by Revenue (2020-2025)
3.1.2 Global Type 2 Diabetes Medication Revenue Market Share by Players (2020-2025)
3.2 Global Type 2 Diabetes Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Type 2 Diabetes Medication Revenue
3.4 Global Type 2 Diabetes Medication Market Concentration Ratio
3.4.1 Global Type 2 Diabetes Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Medication Revenue in 2024
3.5 Global Key Players of Type 2 Diabetes Medication Head office and Area Served
3.6 Global Key Players of Type 2 Diabetes Medication, Product and Application
3.7 Global Key Players of Type 2 Diabetes Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Type 2 Diabetes Medication Breakdown Data by Type
4.1 Global Type 2 Diabetes Medication Historic Market Size by Type (2020-2025)
4.2 Global Type 2 Diabetes Medication Forecasted Market Size by Type (2026-2031)
5 Type 2 Diabetes Medication Breakdown Data by Application
5.1 Global Type 2 Diabetes Medication Historic Market Size by Application (2020-2025)
5.2 Global Type 2 Diabetes Medication Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Type 2 Diabetes Medication Market Size (2020-2031)
6.2 North America Type 2 Diabetes Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Type 2 Diabetes Medication Market Size by Country (2020-2025)
6.4 North America Type 2 Diabetes Medication Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Type 2 Diabetes Medication Market Size (2020-2031)
7.2 Europe Type 2 Diabetes Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Type 2 Diabetes Medication Market Size by Country (2020-2025)
7.4 Europe Type 2 Diabetes Medication Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Type 2 Diabetes Medication Market Size (2020-2031)
8.2 Asia-Pacific Type 2 Diabetes Medication Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2020-2025)
8.4 Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Type 2 Diabetes Medication Market Size (2020-2031)
9.2 Latin America Type 2 Diabetes Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Type 2 Diabetes Medication Market Size by Country (2020-2025)
9.4 Latin America Type 2 Diabetes Medication Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Type 2 Diabetes Medication Market Size (2020-2031)
10.2 Middle East & Africa Type 2 Diabetes Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2020-2025)
10.4 Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Type 2 Diabetes Medication Introduction
11.1.4 AstraZeneca Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Type 2 Diabetes Medication Introduction
11.2.4 Novartis Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Type 2 Diabetes Medication Introduction
11.3.4 Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.3.5 Novo Nordisk Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Type 2 Diabetes Medication Introduction
11.4.4 Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Type 2 Diabetes Medication Introduction
11.5.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Type 2 Diabetes Medication Introduction
11.6.4 Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Type 2 Diabetes Medication Introduction
11.7.4 Eli Lilly Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.7.5 Eli Lilly Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Type 2 Diabetes Medication Introduction
11.8.4 Merck Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Type 2 Diabetes Medication Introduction
11.9.4 Sanofi Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Type 2 Diabetes Medication Introduction
11.10.4 Pfizer Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 Astellas Pharma
11.11.1 Astellas Pharma Company Details
11.11.2 Astellas Pharma Business Overview
11.11.3 Astellas Pharma Type 2 Diabetes Medication Introduction
11.11.4 Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.11.5 Astellas Pharma Recent Development
11.12 Daiichi Sankyo
11.12.1 Daiichi Sankyo Company Details
11.12.2 Daiichi Sankyo Business Overview
11.12.3 Daiichi Sankyo Type 2 Diabetes Medication Introduction
11.12.4 Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.12.5 Daiichi Sankyo Recent Development
11.13 Biocon
11.13.1 Biocon Company Details
11.13.2 Biocon Business Overview
11.13.3 Biocon Type 2 Diabetes Medication Introduction
11.13.4 Biocon Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.13.5 Biocon Recent Development
11.14 Glenmark
11.14.1 Glenmark Company Details
11.14.2 Glenmark Business Overview
11.14.3 Glenmark Type 2 Diabetes Medication Introduction
11.14.4 Glenmark Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.14.5 Glenmark Recent Development
11.15 Bayer AG
11.15.1 Bayer AG Company Details
11.15.2 Bayer AG Business Overview
11.15.3 Bayer AG Type 2 Diabetes Medication Introduction
11.15.4 Bayer AG Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.15.5 Bayer AG Recent Development
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Type 2 Diabetes Medication Introduction
11.16.4 Takeda Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.16.5 Takeda Recent Development
11.17 Sun pharma
11.17.1 Sun pharma Company Details
11.17.2 Sun pharma Business Overview
11.17.3 Sun pharma Type 2 Diabetes Medication Introduction
11.17.4 Sun pharma Revenue in Type 2 Diabetes Medication Business (2020-2025)
11.17.5 Sun pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
Novartis
Novo Nordisk
Johnson & Johnson
Boehringer Ingelheim
Bristol–Myers Squibb
Eli Lilly
Merck
Sanofi
Pfizer Inc
Astellas Pharma
Daiichi Sankyo
Biocon Ltd.
Glenmark
Bayer
Takeda
Sun Pharma
List of Tables
 Table 1. Global Type 2 Diabetes Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Biguanides
 Table 3. Key Players of Sulphonylureas
 Table 4. Key Players of Thiazolidinediones
 Table 5. Key Players of Alpha-glucosidase Inhibitors
 Table 6. Key Players of DPP-4 Inhibitors
 Table 7. Key Players of GLP-1 Receptor Agonists
 Table 8. Key Players of SGLT-2 Inhibitors
 Table 9. Global Type 2 Diabetes Medication Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Type 2 Diabetes Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Type 2 Diabetes Medication Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Type 2 Diabetes Medication Market Share by Region (2020-2025)
 Table 13. Global Type 2 Diabetes Medication Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Type 2 Diabetes Medication Market Share by Region (2026-2031)
 Table 15. Type 2 Diabetes Medication Market Trends
 Table 16. Type 2 Diabetes Medication Market Drivers
 Table 17. Type 2 Diabetes Medication Market Challenges
 Table 18. Type 2 Diabetes Medication Market Restraints
 Table 19. Global Type 2 Diabetes Medication Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Type 2 Diabetes Medication Market Share by Players (2020-2025)
 Table 21. Global Top Type 2 Diabetes Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medication as of 2024)
 Table 22. Ranking of Global Top Type 2 Diabetes Medication Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Type 2 Diabetes Medication Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Type 2 Diabetes Medication, Headquarters and Area Served
 Table 25. Global Key Players of Type 2 Diabetes Medication, Product and Application
 Table 26. Global Key Players of Type 2 Diabetes Medication, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Type 2 Diabetes Medication Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Type 2 Diabetes Medication Revenue Market Share by Type (2020-2025)
 Table 30. Global Type 2 Diabetes Medication Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Type 2 Diabetes Medication Revenue Market Share by Type (2026-2031)
 Table 32. Global Type 2 Diabetes Medication Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Type 2 Diabetes Medication Revenue Market Share by Application (2020-2025)
 Table 34. Global Type 2 Diabetes Medication Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Type 2 Diabetes Medication Revenue Market Share by Application (2026-2031)
 Table 36. North America Type 2 Diabetes Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Type 2 Diabetes Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Type 2 Diabetes Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Type 2 Diabetes Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Type 2 Diabetes Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Type 2 Diabetes Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Type 2 Diabetes Medication Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Type 2 Diabetes Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Type 2 Diabetes Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Type 2 Diabetes Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Type 2 Diabetes Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 51. AstraZeneca Company Details
 Table 52. AstraZeneca Business Overview
 Table 53. AstraZeneca Type 2 Diabetes Medication Product
 Table 54. AstraZeneca Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 55. AstraZeneca Recent Development
 Table 56. Novartis Company Details
 Table 57. Novartis Business Overview
 Table 58. Novartis Type 2 Diabetes Medication Product
 Table 59. Novartis Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 60. Novartis Recent Development
 Table 61. Novo Nordisk Company Details
 Table 62. Novo Nordisk Business Overview
 Table 63. Novo Nordisk Type 2 Diabetes Medication Product
 Table 64. Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 65. Novo Nordisk Recent Development
 Table 66. Johnson & Johnson Company Details
 Table 67. Johnson & Johnson Business Overview
 Table 68. Johnson & Johnson Type 2 Diabetes Medication Product
 Table 69. Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 70. Johnson & Johnson Recent Development
 Table 71. Boehringer Ingelheim Company Details
 Table 72. Boehringer Ingelheim Business Overview
 Table 73. Boehringer Ingelheim Type 2 Diabetes Medication Product
 Table 74. Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 75. Boehringer Ingelheim Recent Development
 Table 76. Bristol-Myers Squibb Company Details
 Table 77. Bristol-Myers Squibb Business Overview
 Table 78. Bristol-Myers Squibb Type 2 Diabetes Medication Product
 Table 79. Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 80. Bristol-Myers Squibb Recent Development
 Table 81. Eli Lilly Company Details
 Table 82. Eli Lilly Business Overview
 Table 83. Eli Lilly Type 2 Diabetes Medication Product
 Table 84. Eli Lilly Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 85. Eli Lilly Recent Development
 Table 86. Merck Company Details
 Table 87. Merck Business Overview
 Table 88. Merck Type 2 Diabetes Medication Product
 Table 89. Merck Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 90. Merck Recent Development
 Table 91. Sanofi Company Details
 Table 92. Sanofi Business Overview
 Table 93. Sanofi Type 2 Diabetes Medication Product
 Table 94. Sanofi Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 95. Sanofi Recent Development
 Table 96. Pfizer Company Details
 Table 97. Pfizer Business Overview
 Table 98. Pfizer Type 2 Diabetes Medication Product
 Table 99. Pfizer Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 100. Pfizer Recent Development
 Table 101. Astellas Pharma Company Details
 Table 102. Astellas Pharma Business Overview
 Table 103. Astellas Pharma Type 2 Diabetes Medication Product
 Table 104. Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 105. Astellas Pharma Recent Development
 Table 106. Daiichi Sankyo Company Details
 Table 107. Daiichi Sankyo Business Overview
 Table 108. Daiichi Sankyo Type 2 Diabetes Medication Product
 Table 109. Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 110. Daiichi Sankyo Recent Development
 Table 111. Biocon Company Details
 Table 112. Biocon Business Overview
 Table 113. Biocon Type 2 Diabetes Medication Product
 Table 114. Biocon Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 115. Biocon Recent Development
 Table 116. Glenmark Company Details
 Table 117. Glenmark Business Overview
 Table 118. Glenmark Type 2 Diabetes Medication Product
 Table 119. Glenmark Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 120. Glenmark Recent Development
 Table 121. Bayer AG Company Details
 Table 122. Bayer AG Business Overview
 Table 123. Bayer AG Type 2 Diabetes Medication Product
 Table 124. Bayer AG Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 125. Bayer AG Recent Development
 Table 126. Takeda Company Details
 Table 127. Takeda Business Overview
 Table 128. Takeda Type 2 Diabetes Medication Product
 Table 129. Takeda Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 130. Takeda Recent Development
 Table 131. Sun pharma Company Details
 Table 132. Sun pharma Business Overview
 Table 133. Sun pharma Type 2 Diabetes Medication Product
 Table 134. Sun pharma Revenue in Type 2 Diabetes Medication Business (2020-2025) & (US$ Million)
 Table 135. Sun pharma Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Type 2 Diabetes Medication Picture
 Figure 2. Global Type 2 Diabetes Medication Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Type 2 Diabetes Medication Market Share by Type: 2024 VS 2031
 Figure 4. Biguanides Features
 Figure 5. Sulphonylureas Features
 Figure 6. Thiazolidinediones Features
 Figure 7. Alpha-glucosidase Inhibitors Features
 Figure 8. DPP-4 Inhibitors Features
 Figure 9. GLP-1 Receptor Agonists Features
 Figure 10. SGLT-2 Inhibitors Features
 Figure 11. Insulins Features
 Figure 12. Global Type 2 Diabetes Medication Market Size by Application (2020-2031) & (US$ Million)
 Figure 13. Global Type 2 Diabetes Medication Market Share by Application: 2024 VS 2031
 Figure 14. Hospital Pharmacies Case Studies
 Figure 15. Retail Pharmacies Case Studies
 Figure 16. Online Pharmacies Case Studies
 Figure 17. Type 2 Diabetes Medication Report Years Considered
 Figure 18. Global Type 2 Diabetes Medication Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Type 2 Diabetes Medication Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Type 2 Diabetes Medication Market Share by Region: 2024 VS 2031
 Figure 21. Global Type 2 Diabetes Medication Market Share by Players in 2024
 Figure 22. Global Top Type 2 Diabetes Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medication as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Type 2 Diabetes Medication Revenue in 2024
 Figure 24. North America Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Type 2 Diabetes Medication Market Share by Country (2020-2031)
 Figure 26. United States Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Type 2 Diabetes Medication Market Share by Country (2020-2031)
 Figure 30. Germany Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Type 2 Diabetes Medication Market Share by Region (2020-2031)
 Figure 38. China Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Type 2 Diabetes Medication Market Share by Country (2020-2031)
 Figure 46. Mexico Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Type 2 Diabetes Medication Market Share by Country (2020-2031)
 Figure 50. Turkey Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Type 2 Diabetes Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. AstraZeneca Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 54. Novartis Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 55. Novo Nordisk Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 56. Johnson & Johnson Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 57. Boehringer Ingelheim Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 59. Eli Lilly Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 60. Merck Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 61. Sanofi Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 62. Pfizer Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 63. Astellas Pharma Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 64. Daiichi Sankyo Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 65. Biocon Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 66. Glenmark Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 67. Bayer AG Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 68. Takeda Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 69. Sun pharma Revenue Growth Rate in Type 2 Diabetes Medication Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Type 2 Diabetes Medications Market Research Report 2024
Global Type 2 Diabetes Medicines Market Research Report 2024
Injectable Drugs For Type 2 Diabete Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Medicines for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Drugs For Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medication for Diabetes Market Research Report 2024
Diabetes Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Type 2 Diabetes Mellitus Treatment Market Research Report 2024
Global Insulin Drugs for Diabetes Market Research Report 2024
Global Diabetes Insulin Delivery Pens Market Insights Forecast to 2030
Oral Hypoglycemic Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti diabetic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antidiabetic Drugs Market Insights Forecast to 2030
Next Generation Diabetes Therapy and Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Pens Market Insights Forecast to 2030
Global Insulin Injection Equipment Market Research Report 2025
Global Oral Insulin Market Research Report 2025
Global Diabetes Mellitus Treatment Market Insights Forecast to 2030
Global Hormonal Therapy for Type 2 Diabetes Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions